About Our Company
Peptimmune is a clinical stage biotechnology company developing peptide and peptide-copolymer therapeutics for the treatment of CNS and Autoimmune disorders. These therapies target MHC Class II molecules and modulating immune responses. Founded in 2002 and located in Cambridge, MA USA, the Company is led by an experienced management team and exploits its proprietary DEEP™ Technology to design peptides and peptide mixtures.
Meet Our Team
Dustan Bonnin PAg, MBA
Director, Technology Management & Intellectual Property
Dustan joined Peptimmune in 2003. As director of technology management and intellectual property, Dustan leverages fifteen years of laboratory experience in academic and industrial immunology. Previously at UCSD and Praecis…